AXIM Biotechnologies, Inc.

AXIM Biotechnologies, Inc. financial statements

AXIM Biotechnologies, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2023

RevenueUSD 39.52K10-K
Net income−USD 8.06M10-K
Cash and equivalentsUSD 156.46K10-Q
Total debtUSD 4.89M10-Q

AXIM Biotechnologies, Inc. financials on 6ix · AXIM Biotechnologies, Inc. on 6ix